Second-Line Pharmaceutical Treatments for Patients with Type 2 Diabetes.
Saved in:
| Title: | Second-Line Pharmaceutical Treatments for Patients with Type 2 Diabetes. |
|---|---|
| Authors: | Vashisht R; Bakar Computational Health Sciences Institute, University of California, San Francisco., Patel A; Bakar Computational Health Sciences Institute, University of California, San Francisco.; Center for Data-driven Insights and Innovation, University of California Health, Oakland., Dahm L; Center for Data-driven Insights and Innovation, University of California Health, Oakland., Han C; Center for Data-driven Insights and Innovation, University of California Health, Oakland., Medders KE; Department of Pharmacy, UC San Diego Health, San Diego, California., Mowers R; Managed Care Pharmacy Services, University of California, Davis School of Medicine, Davis., Byington CL; Center for Data-driven Insights and Innovation, University of California Health, Oakland.; Department of Pediatrics, University of California, San Francisco., Koliwad SK; Division of Endocrinology and Metabolism, Department of Medicine, and Diabetes Center, University of California, San Francisco., Butte AJ; Bakar Computational Health Sciences Institute, University of California, San Francisco.; Center for Data-driven Insights and Innovation, University of California Health, Oakland. |
| Source: | JAMA network open [JAMA Netw Open] 2023 Oct 02; Vol. 6 (10), pp. e2336613. Date of Electronic Publication: 2023 Oct 02. |
| Publication Type: | Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2574-3805 |
|---|---|
| DOI: | 10.1001/jamanetworkopen.2023.36613 |
